a-gene: regulatory considerations
Published 2 years ago • 1.3K plays • Length 59:51Download video MP4
Download video MP3
Similar videos
-
1:02:31
a-cell: regulatory considerations
-
28:59
introduction and industry update - cell & gene state of the industry briefing 2024
-
1:01:03
a-gene: comparability
-
23:40
expediting the development of cell and gene therapy
-
1:06:05
hopes and concerns: how patients and caregivers approach atmps
-
1:45:30
glyphosate, microbiomes & the ecosystem (part 3 of the glyphosate series)
-
14:58
ocugen
-
57:43
strategic manufacturing: build vs. buy for cell and gene therapies
-
1:00:38
critical supply chain and logistics considerations for cell and gene therapy management
-
8:22
representation of women executives in cell & gene therapy: arm studios interview with susan nichols
-
59:24
ethics in gene and cell therapy
-
52:44
a-gene: drug product
-
14:48
overview of the alliance for regenerative medicine’s initiatives
-
15:01
taysha gene therapies
-
1:02:39
a-cell: manufacturing of cell-based therapies
-
1:03:24
a-gene: process control strategy
-
5:20
harnessing cell and gene therapies for ethical purposes: arm studios interview with rob perez
-
59:04
meet the authors: regulation of regenerative medicines: a global perspective
-
47:03
current challenges, opportunities and trends in gene editing and gene therapy workshop
-
1:00:27
innovative payment solutions – recent learnings from gene therapy launches